logo

AbCellera Biologics Inc (ABCL) Stock: 52-Week Performance Insights and Trading Volume

SLGG

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. AbCellera Biologics Inc’s current trading price is -42.62% away from its 52-week high, while its distance from the 52-week low is 31.70%. The stock’s price range over this period has fluctuated between $1.89 and $4.34. The company, operating within the financial sector, had a trading volume of approximately 3.45 million for the day, which was noticeably lower than the average daily share volume of 4.18 million over the last 3 months.

In terms of market performance, AbCellera Biologics Inc had a fairly uneven. The highest value for the stock in the past year was $4.34 on 05/28/24, and the lowest value was recorded at $1.89 on 04/07/25.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

AbCellera Biologics Inc (ABCL) has experienced a quarterly decline of -22.91% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 741.99M and boasts a workforce of 596 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.76, with a change in price of -0.41. Similarly, AbCellera Biologics Inc recorded 3,867,968 in trading volume during the last 100 days, posting a change of -14.14%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ABCL stands at 0.06. Similarly, the long-term debt-to-equity ratio is also 0.06.

ABCL Stock Stochastic Average

Today’s raw stochastic average for AbCellera Biologics Inc over the last 50 days is 37.27%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 75.95%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 83.54% and 85.79%, respectively.

ABCL Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -15.02%.However, over the last six months, we can see a stronger performance of -13.84%. Over the last 30 days, the price of ABCL has fallen by 19.14%. And in the last five days, it has fallen by -4.23%.

Most Popular